Scales to Assess Clinical Features of Progressive Supranuclear Palsy: MDS Task Force Report
Year: 2015
Type: review
Abstract: Author(s): Hall, Deborah A; Forjaz, Maria João; Golbe, Lawrence I; Litvan, Irene; Payan, Christine Ann M; Goetz, Christopher G; Leentjens, Albert FG; Martinez-Martin, Pablo; Traon, Anne Pavy-Le; Sampaio, Cristina; Post, Bart; Stebbins, Glenn; Weintraub, Daniel; Schrag, Anette
DOI: 10.1002/mdc3.12130
Institutions: Rush University, Instituto de Salud Carlos III, Escuela Nacional de Sanidad, Rutgers, The State University of New Jersey, University of California San Diego, Assistance Publique – Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Maastricht University Medical Centre, Biomedical Research Networking Center on Neurodegenerative Diseases, Centro Nacional de Epidemiología, Inserm, University of Lisbon, Radboud University Medical Center, University of Pennsylvania, UCL Queen Square Institute of Neurology, University College London
Language: English
Subfield: Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: U.S. Department of Veterans Affairs, Michael J. Fox Foundation for Parkinson's Research, Bristol-Myers Squibb, Pfizer, American Academy of Neurology, CHDI Foundation, Teva Pharmaceutical Industries, University of Pennsylvania, CurePSP, ACADIA Pharmaceuticals, Neurocrine Biosciences, Avanir Pharmaceuticals, Adamas Pharmaceuticals, Rainwater Charitable Foundation, Parkinson's UK, University of Oxford, European Commission, H. Lundbeck A/S, Italfarmaco, National Institutes of Health, Dystonia Coalition
OpenAlex ID: W2170232798